Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

159 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cutaneous adverse events caused by immune checkpoint inhibitors.
Quach HT, Johnson DB, LeBoeuf NR, Zwerner JP, Dewan AK. Quach HT, et al. Among authors: leboeuf nr. J Am Acad Dermatol. 2021 Oct;85(4):956-966. doi: 10.1016/j.jaad.2020.09.054. Epub 2021 Jul 28. J Am Acad Dermatol. 2021. PMID: 34332798 Review.
Dermatological adverse events with taxane chemotherapy.
Sibaud V, Lebœuf NR, Roche H, Belum VR, Gladieff L, Deslandres M, Montastruc M, Eche A, Vigarios E, Dalenc F, Lacouture ME. Sibaud V, et al. Among authors: leboeuf nr. Eur J Dermatol. 2016 Oct 1;26(5):427-443. doi: 10.1684/ejd.2016.2833. Eur J Dermatol. 2016. PMID: 27550571 Free PMC article. Review.
Rituximab Treatment of Nivolumab-Induced Bullous Pemphigoid.
Sowerby L, Dewan AK, Granter S, Gandhi L, LeBoeuf NR. Sowerby L, et al. Among authors: leboeuf nr. JAMA Dermatol. 2017 Jun 1;153(6):603-605. doi: 10.1001/jamadermatol.2017.0091. JAMA Dermatol. 2017. PMID: 28355425 No abstract available.
Psoriasiform eruptions secondary to phosphoinositide 3-kinase inhibition.
Dewan AK, Gupta S, Bach DQ, Jadeja S, Granter S, LaCasce A, Joyce R, Davids MS, Huang V, LeBoeuf NR. Dewan AK, et al. Among authors: leboeuf nr. JAAD Case Rep. 2019 Apr 20;5(5):401-405. doi: 10.1016/j.jdcr.2018.03.005. eCollection 2019 May. JAAD Case Rep. 2019. PMID: 31049381 Free PMC article. No abstract available.
Nonbullous pemphigoid secondary to PD-1 inhibition.
Singer S, Nelson CA, Lian CG, Dewan AK, LeBoeuf NR. Singer S, et al. Among authors: leboeuf nr. JAAD Case Rep. 2019 Oct 3;5(10):898-903. doi: 10.1016/j.jdcr.2019.07.015. eCollection 2019 Oct. JAAD Case Rep. 2019. PMID: 31646161 Free PMC article. No abstract available.
Bullous pemphigoid after anti-programmed death-1 therapy: A retrospective case-control study evaluating impact on tumor response and survival outcomes.
Nelson CA, Singer S, Chen T, Puleo AE, Lian CG, Wei EX, Giobbie-Hurder A, Mostaghimi A, LeBoeuf NR. Nelson CA, et al. Among authors: leboeuf nr. J Am Acad Dermatol. 2022 Dec;87(6):1400-1402. doi: 10.1016/j.jaad.2019.12.068. Epub 2020 Jan 10. J Am Acad Dermatol. 2022. PMID: 31931083 No abstract available.
Surface applicator high-dose-rate fractionated brachytherapy for superficial cancers of the penis: A single-center case series and national database comparison.
Dee EC, Fefer M, Hammoudeh L, Yu Z, Cantalino JM, Johnson TJ, O'Farrell DA, Bui AN, Muralidhar V, Mahal BA, Nguyen PL, LeBoeuf NR, Devlin PM. Dee EC, et al. Among authors: leboeuf nr. J Am Acad Dermatol. 2021 Jan;84(1):168-172. doi: 10.1016/j.jaad.2020.04.041. Epub 2020 Apr 19. J Am Acad Dermatol. 2021. PMID: 32320768 No abstract available.
159 results